A Redlitz, A K Tan, D L Eaton, E F Plow
Title and authors | Publication | Year |
---|---|---|
Natural and Engineered Plasmin Inhibitors: Applications and Design Strategies
JE Swedberg, JM Harris |
ChemBioChem | 2012 |
Arginine and lysine as products of basic carboxypeptidase activity associated with fibrinolysis
AA Zhloba, TF Subbotina, DS Lupan, VA Bogova, OA Kusheleva |
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | 2012 |
Identification of host genes showing differential expression profiles with cell-based long-term replication of hepatitis C virus RNA
H Sejima, K Mori, Y Ariumi, M Ikeda, N Kato |
Virus Research | 2012 |
Intravenous and oral administrations of DD2 [7-Amino-2-(sulfanylmethyl)heptanoic acid] produce thrombolysis through inhibition of plasma TAFIa in rats with tissue factor-induced microthrombosis
T Sasaki, N Yoshimoto, K Sugimoto, K Takada, N Murayama, H Yamazaki, K Yamamoto, H Ishii |
Thrombosis Research | 2012 |
Dietary zinc depletion and repletion affects plasma proteins: an analysis of the plasma proteome
A Grider, K Wickwire, E Ho, CS Chung, J King |
BioMetals | 2012 |
Peroxisome proliferator-activated receptor-alpha agonists repress expression of thrombin-activatable fibrinolysis inhibitor by decreasing transcript stability:
Y Masuda, D Saotome, K Takada, K Sugimoto, T Sasaki, H Ishii |
Thrombosis and Haemostasis | 2012 |
Fibrinolytic system in preeclampsia
MB Pinheiro, KB Gomes, LM Dusse |
Clinica Chimica Acta | 2012 |
Alternative Mechanism of Aspirin in Anti-Thrombotic Therapy: Inhibition of Thrombin Activatable Fibrinolysis Inhibitor
SS An, RS Greenfield |
Bulletin of the Korean Chemical Society | 2012 |
Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer
M Eser, M Kement, S Balin, C Coskun, U Kefeli, M Gumus, YE Altuntas, N Kurt, A Mayadagli |
World journal of surgical oncology | 2012 |